Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "STC is a buy with a stop loss of Rs 175, target of Rs 190 and Ceat with a stop loss of Rs 1430, target of Rs 1500."
"Dishman Pharma is a buy with a stop loss of Rs 334, target of Rs 348," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
